Adherence

CBX Expert: Biopharma Patients Respond to Better Brand Experiences

Retrieved on: 
Tuesday, May 1, 2018

In the column ("Your Brand is the Patient's Experience"), McDonagh notes that consumer experience and patient adherence are growing concerns in the sector, where a third of all new drug approvals are biologics.

Key Points: 
  • In the column ("Your Brand is the Patient's Experience"), McDonagh notes that consumer experience and patient adherence are growing concerns in the sector, where a third of all new drug approvals are biologics.
  • Over and above creating products that are easy to self-administer, biopharma companies should seek to maximize the patient experience, he writes.
  • In the conclusion to the piece, the CBX strategy director notes that those who are forced to live with chronic diseases will respond to better therapy experiences that improve their lives.
  • Founded in 2003, CBX is a brand agency with expertise in design, strategy, verbal identity and retail environments.

"Knowing But Not Doing: The State of Rx Adherence in America Report" Finds Big Difference in What Americans Know and Do When It Comes to Their Chronic Medications

Retrieved on: 
Wednesday, April 25, 2018

That's according to a new survey, Knowing But Not Doing: The State of Rx Adherence in America Report from Express Scripts (NASDAQ: ESRX).

Key Points: 
  • That's according to a new survey, Knowing But Not Doing: The State of Rx Adherence in America Report from Express Scripts (NASDAQ: ESRX).
  • The Mango app helps patients develop healthy habits and manage their medication adherence by tackling the biggest driver of non-adherence: forgetting.
  • Predicting medication nonadherence before it starts is another way Express Scripts helps patients stay on track with their therapy.
  • Express Scripts also distributes a full range of biopharmaceutical products and offers innovative medical benefit management services.

Siemens Healthineers and Hill-Rom to Provide Comprehensive Diabetes Care for Primary Care Facilities

Retrieved on: 
Monday, May 7, 2018

The patient-centered solution from Siemens Healthineers and Hill-Rom offers physicians more control over patient care by accomplishing proactive testing and treatment during a single visit.

Key Points: 
  • The patient-centered solution from Siemens Healthineers and Hill-Rom offers physicians more control over patient care by accomplishing proactive testing and treatment during a single visit.
  • This improved workflow may reduce costs and eliminate inconvenient follow-up visits, leading to higher patient satisfaction and compliance with care regimens.
  • "Our new commercial relationship with Hill-Rom will provide holistic, easy-to-implement solutions that aid in combating diabetes and related comorbidities while satisfying value-based quality care measures.
  • Siemens Healthineers contributes to the joint offering with point-of-care solutions that aid in combating chronic diseases before they become critical.

Medisafe Demonstrates Double-Digit Impact on Medication Adherence in Hypertension Patients

Retrieved on: 
Monday, May 7, 2018

"We are excited about the topline results of 10% increase in prescription refills, especially because they include a cohort of engaged patients that started using the app already quite successful on their medication regimens.

Key Points: 
  • "We are excited about the topline results of 10% increase in prescription refills, especially because they include a cohort of engaged patients that started using the app already quite successful on their medication regimens.
  • The hypertension results follow data released from the same landmark study in early March on the accuracy of Medisafe's patient reported adherence data .
  • In the coming months, Medisafe will continue to release results, including data regarding the platform's impact on adherence and persistence across other therapeutic areas.
  • Medisafe is the personalized medication management platform addressing all major causes of non-adherence, a $300 billion problem in the US alone.

New York State Psychiatric Association Endorses DrFirst Medication Management Tools for Use by Psychiatric Community in New York State

Retrieved on: 
Saturday, May 5, 2018

As part of this endorsement, NYSPA members will be able to purchase Rcopia , DrFirst's industry-leading, web-based, stand-alone e-prescribing service, at a substantial discount.

Key Points: 
  • As part of this endorsement, NYSPA members will be able to purchase Rcopia , DrFirst's industry-leading, web-based, stand-alone e-prescribing service, at a substantial discount.
  • The company's integrated technologies include its award-winning electronic prescribing platform, the most comprehensive medication history available, clinically specialized secure messaging, as well as patient medication adherence monitoring and benefits checking.
  • In addition, DrFirst was the first to offer e-prescribing for controlled substances (EPCS), which is considered the industry standard for providers nationwide.
  • For more information, please visit www.drfirst.com or connect with us @DrFirst .

Prime Therapeutics Finds Poor Adherence to High-Cost Multiple Sclerosis Therapy

Retrieved on: 
Monday, April 23, 2018

For both studies, Prime researchers evaluated commercially insured members who were continuously enrolled from October 2013 to September 2017 and younger than 65 years old.

Key Points: 
  • For both studies, Prime researchers evaluated commercially insured members who were continuously enrolled from October 2013 to September 2017 and younger than 65 years old.
  • Adherence was defined as those patients who showed 80 percent or greater proportion of days covered (PDC) with a DMD.
  • "This real-world study shows that DMD adherence was associated with a significant decrease in relapses, which is a major goal of therapy," said Kevin Bowen, M.D., principal health outcomes researcher at Prime.
  • Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well.

SAI Global Report Uncovers Gap between Regulator Expectations and the Reality of U.S. Healthcare Compliance Programs

Retrieved on: 
Thursday, April 19, 2018

The study, conducted jointly by SAI Global and Strategic Management Services, a leading expert in corporate compliance, was designed to gain an understanding of issues currently confronting compliance programs and how compliance officers are responding to them.

Key Points: 
  • The study, conducted jointly by SAI Global and Strategic Management Services, a leading expert in corporate compliance, was designed to gain an understanding of issues currently confronting compliance programs and how compliance officers are responding to them.
  • Data was gathered from 388 healthcare organizations across all sectors, from physician practices to large integrated hospital systems.
  • A trend found in the SAI Global surveys is the accretion of new duties and responsibilities for compliance offices surveyed.
  • This report represents SAI Global's ninth annual survey gathering data from healthcare industry compliance professionals.

GDPR Preparation and Challenges Survey Report Explores Overall Industry Preparedness in Achieving Compliance

Retrieved on: 
Wednesday, April 18, 2018

"Together with Netskope, we wanted to add to the industry's knowledge and preparedness of GDPR and highlight the GDPR's impact on the industry."

Key Points: 
  • "Together with Netskope, we wanted to add to the industry's knowledge and preparedness of GDPR and highlight the GDPR's impact on the industry."
  • "Alarmingly, 27 percent of survey respondents reported having little to no familiarity with the GDPR even with the deadline for compliance a little more than a month away.
  • Seventy-one percent of the respondents feel confident that their organizations will meet GDPR compliance in time.
  • Thirty-one percent of companies have well-defined plans for meeting GDPR compliance, 85 percent have something in place, and 73 percent have begun executing that plan.

Sempre Health and Novo Nordisk Partner to Improve Medication Costs for Patients With Diabetes

Retrieved on: 
Wednesday, April 18, 2018

SAN FRANCISCO, April 18, 2018 /PRNewswire/ --Sempre Health, the leading solution for behavior-based healthcare pricing, today announced it's collaborating on a pilot program with Novo Nordisk to add diabetes medications to the Sempre Health affordability & engagement solution.

Key Points: 
  • SAN FRANCISCO, April 18, 2018 /PRNewswire/ --Sempre Health, the leading solution for behavior-based healthcare pricing, today announced it's collaborating on a pilot program with Novo Nordisk to add diabetes medications to the Sempre Health affordability & engagement solution.
  • "We are excited to combine Sempre's nuanced approach to affordability and adherence with Novo Nordisk's innovative portfolio of medications," said Anurati Mathur, CEO of Sempre Health.
  • The two companies are seeking to engage 10,000 patients with diabetes on the Sempre Health platform in 2018.
  • Taking medication as prescribed, particularly diabetes medication, is tied to better clinical outcomes and reduced healthcare costs.